Concepts (176)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Atrial Fibrillation | 24 | 2024 | 719 | 6.330 |
Why?
|
| Catheter Ablation | 13 | 2023 | 620 | 5.210 |
Why?
|
| Cardiac Resynchronization Therapy | 7 | 2023 | 36 | 4.130 |
Why?
|
| Pulmonary Veins | 3 | 2023 | 174 | 2.300 |
Why?
|
| Heart Failure | 10 | 2023 | 2516 | 1.860 |
Why?
|
| Heart Atria | 8 | 2023 | 352 | 1.830 |
Why?
|
| Tachycardia, Ventricular | 5 | 2023 | 239 | 1.650 |
Why?
|
| Esophagus | 3 | 2021 | 553 | 1.610 |
Why?
|
| Anti-Arrhythmia Agents | 3 | 2019 | 226 | 1.200 |
Why?
|
| Gadolinium | 5 | 2021 | 164 | 1.120 |
Why?
|
| Defibrillators, Implantable | 2 | 2021 | 221 | 1.070 |
Why?
|
| Magnetic Resonance Imaging | 7 | 2021 | 7702 | 1.000 |
Why?
|
| Arrhythmias, Cardiac | 6 | 2023 | 473 | 0.940 |
Why?
|
| Equipment Failure | 2 | 2015 | 191 | 0.930 |
Why?
|
| Bundle-Branch Block | 3 | 2023 | 43 | 0.790 |
Why?
|
| Cryosurgery | 1 | 2022 | 167 | 0.770 |
Why?
|
| Long QT Syndrome | 1 | 2021 | 92 | 0.750 |
Why?
|
| Burns | 1 | 2021 | 117 | 0.740 |
Why?
|
| Heart Rate | 3 | 2022 | 737 | 0.740 |
Why?
|
| Cardiac Imaging Techniques | 1 | 2019 | 46 | 0.690 |
Why?
|
| Meglumine | 1 | 2018 | 20 | 0.640 |
Why?
|
| Contrast Media | 4 | 2021 | 1472 | 0.640 |
Why?
|
| Electrocardiography | 8 | 2023 | 1145 | 0.640 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 5 | 2009 | 244 | 0.640 |
Why?
|
| Esophageal Diseases | 1 | 2018 | 69 | 0.630 |
Why?
|
| Death, Sudden, Cardiac | 2 | 2021 | 253 | 0.630 |
Why?
|
| Heart Conduction System | 5 | 2023 | 165 | 0.610 |
Why?
|
| Organometallic Compounds | 1 | 2018 | 191 | 0.580 |
Why?
|
| Cardiomyopathies | 3 | 2023 | 610 | 0.560 |
Why?
|
| Pacemaker, Artificial | 2 | 2022 | 213 | 0.560 |
Why?
|
| Stroke | 2 | 2023 | 1144 | 0.560 |
Why?
|
| Cardiac Resynchronization Therapy Devices | 1 | 2015 | 12 | 0.530 |
Why?
|
| Device Removal | 2 | 2016 | 337 | 0.510 |
Why?
|
| Fibrosis | 6 | 2023 | 793 | 0.500 |
Why?
|
| Myocardium | 2 | 2019 | 1313 | 0.490 |
Why?
|
| Wounds and Injuries | 1 | 2018 | 399 | 0.480 |
Why?
|
| Treatment Outcome | 17 | 2023 | 32848 | 0.460 |
Why?
|
| Evidence-Based Medicine | 1 | 2019 | 1085 | 0.460 |
Why?
|
| Heart | 1 | 2019 | 1223 | 0.440 |
Why?
|
| Medical Errors | 1 | 2015 | 219 | 0.440 |
Why?
|
| Baseball | 1 | 2013 | 72 | 0.430 |
Why?
|
| Humans | 43 | 2024 | 261506 | 0.410 |
Why?
|
| Kidney Failure, Chronic | 2 | 2022 | 960 | 0.390 |
Why?
|
| Sarcoplasmic Reticulum | 2 | 2009 | 191 | 0.350 |
Why?
|
| Intensive Care Units | 1 | 2014 | 717 | 0.340 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 2403 | 0.330 |
Why?
|
| Stroke Volume | 4 | 2023 | 577 | 0.330 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2009 | 184 | 0.320 |
Why?
|
| Calcium | 3 | 2009 | 1537 | 0.310 |
Why?
|
| Ventricular Function, Left | 4 | 2023 | 603 | 0.300 |
Why?
|
| Renal Dialysis | 1 | 2014 | 945 | 0.290 |
Why?
|
| Biomarkers | 1 | 2018 | 5047 | 0.290 |
Why?
|
| Recurrence | 3 | 2023 | 4758 | 0.270 |
Why?
|
| Malignant Hyperthermia | 1 | 2005 | 23 | 0.270 |
Why?
|
| Cardiology | 2 | 2022 | 530 | 0.270 |
Why?
|
| Tacrolimus Binding Protein 1A | 1 | 2004 | 22 | 0.250 |
Why?
|
| Hot Temperature | 1 | 2005 | 281 | 0.250 |
Why?
|
| Cardiac Conduction System Disease | 1 | 2023 | 12 | 0.230 |
Why?
|
| Atrial Appendage | 2 | 2015 | 55 | 0.230 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2023 | 66 | 0.230 |
Why?
|
| Sick Sinus Syndrome | 1 | 2022 | 14 | 0.220 |
Why?
|
| Cardiac Electrophysiology | 1 | 2022 | 10 | 0.220 |
Why?
|
| Sinoatrial Node | 1 | 2022 | 22 | 0.220 |
Why?
|
| Male | 18 | 2023 | 123000 | 0.220 |
Why?
|
| Anesthesia | 1 | 2005 | 296 | 0.210 |
Why?
|
| Ecosystem | 1 | 2022 | 111 | 0.200 |
Why?
|
| Aged | 14 | 2023 | 70117 | 0.200 |
Why?
|
| Pericardial Effusion | 1 | 2022 | 118 | 0.200 |
Why?
|
| Catheters | 1 | 2022 | 126 | 0.200 |
Why?
|
| Electronics | 1 | 2021 | 58 | 0.200 |
Why?
|
| Cardiovascular System | 1 | 2022 | 145 | 0.190 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2021 | 112 | 0.180 |
Why?
|
| Action Potentials | 2 | 2021 | 560 | 0.180 |
Why?
|
| Esophagoscopy | 1 | 2021 | 291 | 0.170 |
Why?
|
| Inflammasomes | 1 | 2021 | 161 | 0.170 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2023 | 435 | 0.170 |
Why?
|
| Retrospective Studies | 6 | 2023 | 37905 | 0.170 |
Why?
|
| Middle Aged | 12 | 2023 | 86204 | 0.170 |
Why?
|
| Sorting Nexins | 1 | 2018 | 17 | 0.170 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2018 | 38 | 0.170 |
Why?
|
| Equipment Design | 3 | 2022 | 1204 | 0.170 |
Why?
|
| Myocardial Infarction | 2 | 2018 | 1374 | 0.160 |
Why?
|
| Methylamines | 1 | 2018 | 21 | 0.160 |
Why?
|
| Syndrome | 1 | 2021 | 1351 | 0.160 |
Why?
|
| Female | 13 | 2023 | 141928 | 0.150 |
Why?
|
| Ischemic Attack, Transient | 1 | 2017 | 55 | 0.150 |
Why?
|
| Oxides | 1 | 2018 | 211 | 0.150 |
Why?
|
| Operative Time | 1 | 2018 | 217 | 0.150 |
Why?
|
| Equipment Failure Analysis | 2 | 2015 | 329 | 0.150 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2017 | 136 | 0.140 |
Why?
|
| Follow-Up Studies | 3 | 2021 | 14889 | 0.140 |
Why?
|
| Cicatrix | 1 | 2018 | 208 | 0.140 |
Why?
|
| Health Status | 1 | 2019 | 590 | 0.130 |
Why?
|
| Recovery of Function | 1 | 2019 | 703 | 0.130 |
Why?
|
| Suture Techniques | 2 | 2015 | 319 | 0.130 |
Why?
|
| Time Factors | 2 | 2021 | 12926 | 0.130 |
Why?
|
| Compassionate Use Trials | 1 | 2015 | 21 | 0.130 |
Why?
|
| Consensus | 1 | 2019 | 978 | 0.130 |
Why?
|
| Aged, 80 and over | 5 | 2023 | 29902 | 0.130 |
Why?
|
| Pericardium | 1 | 2015 | 157 | 0.120 |
Why?
|
| Radiography, Thoracic | 1 | 2016 | 462 | 0.110 |
Why?
|
| Single-Blind Method | 1 | 2014 | 409 | 0.110 |
Why?
|
| Genome-Wide Association Study | 1 | 2021 | 2265 | 0.110 |
Why?
|
| Reproducibility of Results | 1 | 2022 | 6009 | 0.100 |
Why?
|
| Inflammation | 1 | 2021 | 2522 | 0.100 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 4320 | 0.090 |
Why?
|
| Goats | 1 | 2009 | 73 | 0.090 |
Why?
|
| Cyclic AMP Response Element Modulator | 1 | 2009 | 31 | 0.090 |
Why?
|
| Utah | 2 | 2020 | 43 | 0.090 |
Why?
|
| Predictive Value of Tests | 1 | 2018 | 4892 | 0.080 |
Why?
|
| Caffeine | 2 | 2006 | 87 | 0.080 |
Why?
|
| Obesity | 1 | 2021 | 2884 | 0.080 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2009 | 127 | 0.080 |
Why?
|
| Cardiac Surgical Procedures | 2 | 2020 | 1237 | 0.080 |
Why?
|
| Cardiovascular Diseases | 1 | 2021 | 2195 | 0.080 |
Why?
|
| Incidence | 2 | 2017 | 5673 | 0.080 |
Why?
|
| Tacrolimus Binding Proteins | 1 | 2008 | 87 | 0.080 |
Why?
|
| Risk Factors | 3 | 2021 | 17523 | 0.070 |
Why?
|
| Anticoagulants | 1 | 2013 | 787 | 0.070 |
Why?
|
| Catecholamines | 1 | 2006 | 101 | 0.070 |
Why?
|
| Isoflurane | 1 | 2005 | 67 | 0.070 |
Why?
|
| Muscle Contraction | 1 | 2005 | 218 | 0.060 |
Why?
|
| Arrhythmogenic Right Ventricular Dysplasia | 1 | 2004 | 29 | 0.060 |
Why?
|
| Anesthetics | 1 | 2005 | 115 | 0.060 |
Why?
|
| Mice, Transgenic | 2 | 2009 | 4143 | 0.060 |
Why?
|
| Smartphone | 1 | 2023 | 34 | 0.060 |
Why?
|
| Glucosides | 1 | 2024 | 64 | 0.060 |
Why?
|
| Ventricular Fibrillation | 1 | 2023 | 61 | 0.060 |
Why?
|
| Benzhydryl Compounds | 1 | 2024 | 85 | 0.060 |
Why?
|
| Peptides | 1 | 2009 | 1479 | 0.060 |
Why?
|
| Mice | 5 | 2021 | 34495 | 0.060 |
Why?
|
| Myocytes, Cardiac | 1 | 2008 | 764 | 0.050 |
Why?
|
| Kv1.5 Potassium Channel | 1 | 2021 | 8 | 0.050 |
Why?
|
| Italy | 1 | 2022 | 236 | 0.050 |
Why?
|
| Sheep, Domestic | 1 | 2021 | 21 | 0.050 |
Why?
|
| Pharmacogenomic Testing | 1 | 2021 | 46 | 0.050 |
Why?
|
| India | 1 | 2022 | 301 | 0.050 |
Why?
|
| Phosphorylation | 1 | 2009 | 4804 | 0.050 |
Why?
|
| Disease Models, Animal | 2 | 2021 | 7222 | 0.050 |
Why?
|
| Pharmacogenetics | 1 | 2021 | 260 | 0.040 |
Why?
|
| Valine | 1 | 2020 | 176 | 0.040 |
Why?
|
| Calcium Signaling | 1 | 2021 | 284 | 0.040 |
Why?
|
| Animals | 5 | 2021 | 59536 | 0.040 |
Why?
|
| Genetic Loci | 1 | 2021 | 481 | 0.040 |
Why?
|
| Hospitals | 1 | 2022 | 485 | 0.040 |
Why?
|
| Muscle, Skeletal | 1 | 2005 | 1270 | 0.040 |
Why?
|
| Protein Binding | 1 | 2004 | 3438 | 0.040 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2019 | 624 | 0.040 |
Why?
|
| Adult | 3 | 2022 | 77950 | 0.040 |
Why?
|
| Mutation | 2 | 2006 | 15179 | 0.030 |
Why?
|
| Young Adult | 1 | 2014 | 21445 | 0.030 |
Why?
|
| Equipment Safety | 1 | 2015 | 64 | 0.030 |
Why?
|
| Ligation | 1 | 2015 | 193 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2020 | 2292 | 0.030 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2020 | 799 | 0.030 |
Why?
|
| Cause of Death | 1 | 2017 | 752 | 0.030 |
Why?
|
| Genetic Testing | 1 | 2021 | 1589 | 0.030 |
Why?
|
| Contraindications | 1 | 2013 | 150 | 0.030 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2013 | 126 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2021 | 5539 | 0.030 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2015 | 500 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2021 | 5710 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2021 | 6100 | 0.020 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2013 | 303 | 0.020 |
Why?
|
| United States | 2 | 2021 | 15433 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2021 | 6942 | 0.020 |
Why?
|
| Disease Progression | 1 | 2020 | 6682 | 0.020 |
Why?
|
| Tetracaine | 1 | 2008 | 9 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2020 | 9244 | 0.020 |
Why?
|
| Comorbidity | 1 | 2013 | 2352 | 0.020 |
Why?
|
| Quality of Life | 1 | 2020 | 4532 | 0.020 |
Why?
|
| Vasoconstrictor Agents | 1 | 2006 | 151 | 0.020 |
Why?
|
| Epinephrine | 1 | 2006 | 255 | 0.020 |
Why?
|
| Central Nervous System Stimulants | 1 | 2006 | 225 | 0.020 |
Why?
|
| Survival Rate | 1 | 2017 | 12221 | 0.010 |
Why?
|
| Prognosis | 1 | 2017 | 21713 | 0.010 |
Why?
|